Search
for
Sort by
Research 601–630 of 1000+
- Serum level of vitamin D in patients with alopecia areata
- 649 Gut microbiota plays a role in the development of alopecia areata
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study
- Topical calcipotriol mixed with topical steroid versus topical steroid alone in treatment of alopecia areata
- 164 Epigenetic and transcriptional profiling of PBMCs in mild and severe alopecia areata using single-cell RNA-Seq and ATAC-Seq
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- IL-3 contributes to development of lupus nephritis in MRL/Ipr mice
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- RETRACTED: Genetic association between asthma and alopecia areata: A two‐sample Mendelian randomization study
- Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Periplaneta americana extract (L.) promotes hair regrowth in Alopecia areata mice by reducing inflammation and modulating skin microbiota
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Laser Capture Microdissection Reveals Transcriptional Abnormalities in Alopecia Areata before, during, and after Active Hair Loss
- Antroquinonol Exerts Immunosuppressive Effect on CD8<sup>+</sup> T Cell Proliferation and Activation to Resist Depigmentation Induced by H<sub>2</sub>O<sub>2</sub>
- DcR3 reprograms macrophage plasticity to promote wound healing and hair regeneration
- Comorbid Bronchial Asthma, Atopic Dermatitis and Hashimoto's Thyroiditis Are Risk Factors for Early‐Onset, Severe and Prolonged Alopecia Areata
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- Efficacy and safety of methotrexate in alopecia areata
- The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases